J Clin Microbiol 2000, 38:3686–3688.PubMed 21. Krishnamurthy A, Almeida D, Rodrigues C, Mehta A: Comparison of pyrazinamide drug susceptibility of M. tuberculosis by radiometric Bactec and enzymatic pyrazinamidase assay. Indian. J Med Microbiol 2004, 22:166–168. 22. Singh P, Wesley C, Jadaun GPS, Malonia SK, Das R, Upadhyay P, Faujdar J, Sharma P, Gupta P, Mishra AK, Singh K, Chauhan DS, Sharma VD, Gupta UD, Venkatesan K, Katoch VM: PD173074 Comparative evaluation of Lowenstein-Jensen proportion method, BacT/ALERT 3 D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis

. J Clin Microbiol 2007, 45:76–80.PubMedCrossRef 23. Pransucharit V, Chuchottaworn C: Detection of initial drug resistance of pyrazinamide in Thai tuberculosis patients by radiometric method. Thai J Tuberc Chest Dis 1995, 16:59–65. 24. Chaiprasert A, Prammananan T, Tingtoy N, Na-Ubol P, Srimuang S, Samerpitak K, Rangsipanuratn W: One-tube multiplex PCR method for rapid identification of Mycobacterium tuberculosis . Southeast Asian J Trop Med Public Health 2006, 37:494–502.PubMed 25. Kent PT, Kubica GP: Plublic health mycobacteriology.

A guide for the level III laboratory. Atlanta: US Department of health and human service; 1985. 26. Wayne LG: Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974, 109:147–151.PubMed 27. see more Cheunoy W, Prammananan T, Chaiprasert A, Foongladda S: Comparative evaluation of polymerase chain reaction and restriction enzyme analysis: two amplified targets, hsp65 and rpoB for identification of cultured mycobacteria. Diagn Microbiol Infect Dis 2005, 51:165–171.PubMedCrossRef 28. Hou L, Osei-Hyiaman D, Zhang Z, Wang B, Yang A, Kano K: Molecular characterization of pncA gene Bcl-w mutations in Mycobacterium tuberculosis

clinical isolates from China. Epidemiol Infect 2000, 124:227–232.PubMedCrossRef 29. Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF: Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007, 59:866–873.PubMedCrossRef 30. Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V: Characterization of new mutations in Pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrob Agents Chemother 1999, 43:1761–1763.PubMed 31. Lemaitre N, Callebaut I, Frenois F, Jarlier V, Sougakoff W: Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis . Biochem J 2001, 353:453–458.PubMedCrossRef 32. Du X, Wang W, Kim R, Yakota H, Nguyen H, Kim SH: Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii . Biochemistry 2001, 40:14166–14172.PubMedCrossRef 33.